Home/Filings/4/0001641172-25-023275
4//SEC Filing

Lorber Timothy J. 4

Accession 0001641172-25-023275

CIK 0001757499other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 9:22 PM ET

Size

7.8 KB

Accession

0001641172-25-023275

Insider Transaction Report

Form 4
Period: 2025-08-08
Lorber Timothy J.
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Unit

    2025-08-08+29,24029,240 total
    Common Stock (29,240 underlying)
  • Award

    Restricted Stock Unit

    2025-08-08+24,85424,854 total
    Common Stock (24,854 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.
  • [F2]One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.
  • [F3]These RSUs will vest on 02/08/2026.

Documents

1 file

Issuer

Shuttle Pharmaceuticals Holdings, Inc.

CIK 0001757499

Entity typeother

Related Parties

1
  • filerCIK 0002027850

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 9:22 PM ET
Size
7.8 KB